Your search returned 53 studies. (Get alerts for new studies):
- Docetaxel With or Without Phenoxodiol in Treating Patients With Recurrent Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Perito
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cavity Cancer
1 Location available
- Recombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epitheli
Conditions: Ovarian Cancer - Primary Peritoneal Cavity Cancer
1 Location available
- Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Malignant Tumor of Peritoneum
245 Locations available
- Viral Therapy in Treating Patients With Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Did Not Respond to Platinu
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cavity Cancer
1 Location available
- Safety Study Involving Oxaliplatin With Docetaxel for Recurrent Ovarian,Primary Peritoneal, and Fallopian Tube Cancer
Conditions: Ovarian Cancer - Peritoneal Cancer - Fallopian Tube Cancer
1 Location available
- OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
29 Locations available
- Bevacizumab With or Without Everolimus in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
23 Locations available
- Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
1 Location available
- Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian T
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
98 Locations available
- Surgery and Oxaliplatin or Mitomycin C in Treating Patients With Primary Appendiceal Tumor
Conditions: Peritoneal Cavity Cancer
2 Locations available
- Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer - Psychosocial Effects of Cancer and Its Treatment
126 Locations available
- Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Ovarian Epithelial Canc
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
17 Locations available
- ABT-888 and Topotecan Hydrochloride in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Ovarian Epithelial Cancer or Primary Per
Conditions: Ovarian Cancer - Primary Peritoneal Cavity Cancer - Unspecified Adult Solid Tumor, Protocol Specific
3 Locations available
- Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Cancer
1 Location available
- Study of Pazopanib and Doxil in Patients With Advanced Relapsed Platinum-Sensitive or Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Carcinoma
4 Locations available
- AMG 102 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Malignant Tumor of Peritoneum
30 Locations available
- Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Prim
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
7 Locations available
- Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Rec
Conditions: Cognitive/Functional Effects - Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
164 Locations available
- Irinotecan and Bevacizumab for Recurrent Ovarian Cancer
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Carcinoma
2 Locations available
- First-line Treatment of Weekly Paclitaxel With Carboplatin and Bevacizumab in Ovarian Cancer
Conditions: Epithelial Ovarian Cancer - Primary Peritoneal Cancer - Fallopian Tube Cancer
1 Location available
- Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Cancer - Breast Cancer
1 Location available
- Cediranib and Olaparib in Combination for Recurrent Ovarian or Triple-Negative Breast Cancer
Conditions: Ovarian Cancer - Primary Peritoneal Cancer - Fallopian Tube Cancer
5 Locations available
- EGEN-001 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
11 Locations available
- Safety and Efficacy Study of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Conditions: Fallopian Tube Neoplasms - Ovarian Cancer - Primary Peritoneal
1 Location available
- N-acetylcysteine Given IV With Cisplatin and Paclitaxel in Patients With Ovarian Cancer
Conditions: Ovarian Carcinoma, Stage 3 or 4 - Epithelial Ovarian Carcinoma - Primary Peritoneal Carcinoma
1 Location available
- Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer
Conditions: Breast Cancer - Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
119 Locations available
- Neoadjuvant Therapy for Ovarian Cancer
Conditions: Epithelial Ovarian Cancer - Primary Peritoneal Cancer - Fallopian Tube Cancer
4 Locations available
- RO4929097 in Treating Patients With Recurrent and/or Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cavity Cancer
1 Location available
- Phase II of Carbo/Pralatrexate in Rec. Platinum-Sensitive Ovarian, Fallopian or Primary Peritoneal Cancer
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Cancer
2 Locations available
- Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal C
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
5 Locations available
- SJG-136 in Treating Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer That Did Not Respond to Previous Treatment With Cis
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cavity Cancer
1 Location available
- Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer
Conditions: Ovarian Cancer - Epithelial Ovarian Cancer - Fallopian Tube Carcinoma - Primary Peritoneal Carcinoma
1 Location available
- TRINOVA-1: A Study of AMG 386 or Placebo, in Combination With Weekly Paclitaxel Chemotherapy, as Treatment for Ovarian Cancer, Primary Peritoneal Canc
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cancer
26 Locations available
- A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers
Conditions: Locally Advanced/Metastatic or Recurrent Ovarian Cancer, Fallopian Tube Cancer, - Primary Peritoneal Cancer or Endometrial Cancer - Locally Advanced/Metastatic Her2 Non Overexpressing Breast Cancer
3 Locations available
- Olaparib in Combination With Carboplatin for Refractory or Recurrent Women's Cancers
Conditions: Mixed Muellerian Cancer - Cervical Cancer - Ovarian Cancer - Breast Cancer - Primary Peritoneal Cancer - Fallopian Tube Cancer - Endometrial Cancer - Carcinosarcoma
1 Location available
- Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Conditions: Neoplasms - Ovarian Neoplasms - Fallopian Tube Neoplasms - Primary Peritoneal Neoplasm
5 Locations available
- MK-2206 in the Treatment of Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Cancer
1 Location available
- VTX-2337 and Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal C
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
6 Locations available
- Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
8 Locations available
- Panitumumab and Gemcitabine in Relapsed Ovarian Cancer
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Cancer
1 Location available
- Bevacizumab With or Without Fosbretabulin Tromethamine in Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavi
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
72 Locations available
- Therapeutic Targeting of Stress Factors in Ovarian Cancer Patients
Conditions: Invasive Epithelial Ovarian Cancer - Primary Peritoneal Carcinoma - Fallopian Tube Cancer
1 Location available
- Autologous T-Cells Combined With Autologous OC-DC Vaccine in Ovarian Cancer
Conditions: Ovarian Carcinoma - Fallopian Tube Cancer - Primary Peritoneal Cancer
1 Location available
- Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavit
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
101 Locations available
- Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
Conditions: Anxiety Disorder - Fallopian Tube Cancer - Fatigue - Nausea and Vomiting - Neurotoxicity - Ovarian Cancer - Primary Peritoneal Cavity Cancer
88 Locations available
- Evaluation of TRC105 in the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma
Conditions: Recurrent Ovarian Cancer - Fallopian Tube Carcinoma - Primary Peritoneal Carcinoma
6 Locations available
- Acute Normovolemic Hemodilution in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian Cancer
Conditions: Epithelial Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Carcinoma
1 Location available
- Veliparib, Pegylated Liposomal Doxorubicin Hydrochloride, and Carboplatin in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cance
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
4 Locations available
- Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
79 Locations available
- Beta-Blocker / Ovarian
Conditions: Ovarian Cancer - Primary Peritoneal Carcinoma - Fallopian Tube Cancer
1 Location available
- Veliparib in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Conditions: brca1 Mutation Carrier - brca2 Mutation Carrier - Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
30 Locations available
- A Evaluation of Metformin, Targeting Cancer Stem Cells for the Prevention of Relapse in Patients With Stage IIC/III/IV Ovarian, Fallopian Tube, and Pr
Conditions: Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
1 Location available
- Surgery and Oxaliplatin or Mitomycin C in Treating Patients With Tumors of the Appendix
Conditions: Carcinoma of the Appendix - Primary Peritoneal Cavity Cancer
3 Locations available
|